Annual Review of the Rationale for Strategic Shareholdings and Consideration of Sales
First written in FY2019. 4 of 8 entries say "Advanced", first in FY2024. Latest entry: FY2026.
- FY2026AdvancedAnnual report
「Shares other than unlisted shares 13 982」
Regarding cross-shareholdings, the company sold 13 listed issues for ¥982 million during the fiscal year, continuing to reduce holdings based on its annual review of their rationale. - 2026-06-05AdvancedFinancial results presentation
「Continued reduction of cross-shareholdings < Cash flow from investing activities > Fiscal year ended March 2025 ¥1,276 million Fiscal year ended March 2026 ¥1,015 million」
The company reported additional progress in reducing cross-shareholdings, including ¥1,015 million in proceeds from the sale of investment securities during the fiscal year ended March 2026. - FY2025AdvancedAnnual report
「Shares other than unlisted shares 8 1,276」
Regarding cross-shareholdings, the company sold 8 listed issues for ¥1,276 million during the fiscal year, with the annual review of their rationale and consideration of sales resulting in a further reduction in holdings. - FY2024AdvancedAnnual report
「Shares other than unlisted shares 5 1,200」
Regarding cross-shareholdings, the company sold 5 listed issues for ¥1,200 million during the fiscal year. The annual review of their rationale and consideration of sales have progressed into an actual reduction in holdings. - FY2022RestatedAnnual report
「As a method of reviewing the rationale for holding shares, each year we prepare a "Statement of Reasons for Holding Cross-Shareholdings" for each issue and, based on the relevant business partner's situation and the status of transactions, individually determine at meetings of the Board of Directors whether holding each issue as a cross-shareholding is appropriate under our policy, considering the sale of issues for which no rationale for holding can be identified.」
The company continues to prepare statements of reasons for each issue, conduct annual reviews of their rationale, and consider selling issues with no rationale. - FY2021RestatedAnnual report
「Each year, we prepare a "Statement of Reasons for Holding Cross-Shareholdings" for each issue, assess whether holding each issue as a cross-shareholding is appropriate under our policy in light of the relevant business partner's situation and the status of transactions, and consider selling issues for which no rationale for holding can be identified.」
The company has reconfirmed its process of preparing statements of reasons for each issue, conducting annual reviews of their rationale, and considering the sale of issues with no rationale. - FY2020RestatedAnnual report
「Each year, we prepare a "Statement of Reasons for Holding Cross-Shareholdings" for each issue and, based on the relevant business partner's situation and the status of transactions, individually determine at meetings of the Board of Directors whether holding each issue as a cross-shareholding is appropriate under our policy, considering the sale of issues for which no rationale for holding can be identified.」
The company continues to prepare statements of reasons for each issue, conduct annual reviews of their rationale, and consider selling issues with no rationale. - FY2019First statedAnnual report
「Each year, we prepare a "Statement of Reasons for Holding Cross-Shareholdings" for each issue, assess whether holding each issue as a cross-shareholding is appropriate under our policy in light of the relevant business partner's situation and the status of transactions, and consider selling issues for which no rationale for holding can be identified.」
The company has outlined a management process of preparing a statement of reasons for each issue, reviewing the rationale for holding it, and considering the sale of issues with no rationale.